Adrián Llereda

Prof. Dr. Adrián LLerena has received his PhD in Medicine and Surgery (Clinical Pharmacology/ Pharmacogenetics) in the University of Extremadura, Spain in 1988 prior his Post Doc in Clinical Pharmacogenetics at Karolinska Institute Department of Clinical Pharmacology (1989-1992). Currently, he is working as Director of Clinical Research Center in Extremadura University Hospital and Medical School. He has successfully completed his Administrative responsibilities as Vicedean of the Faculty of Medicine, Rectorate Office for Cooperation Development, and currently is a member of Pharmacogenomics Working Parthy at European Medicines Agency EMA for second term (2014-). His research has included Clinical Pharmacogenetics, Psychopharmacology. Based on this research and fellowship training he has received several awards and honors, such as Latinoamerican Association of National Societies of Pharmacology ALF Award for personal contribution to the development of Pharmacogenomics in Latinamerica (Havana LATINFARMA 2013). He is serving as an editorial member of several reputed journals like The Pharmacogenomics Journal (Associate Editor), DMPT (Editor in Chief), CCPM (Editor in chief), Pharmacogenomics, etc & Expert Reviewers for more thatn 20 journals like Clinical Pharmacology and Therapeutics, British Journal of Clinical Pharmacology. He has authored 190 papers (PubMed) (40 h index). He is Vicepresident of the Spanish Society of Pharmacogenetics and Pharmacogenomics, and he is past Vicepresident of the Spanish Society of Clinical Pharmacology. Founder and former Vicepresident of European Society of Pharmacogenetics and Theranostics (ESPT), founder and Coordinator of the Iberoamerican Network of Pharmacogenetics and Pharmacogenomics RIBEF (2006-). He has been the Director of 21 PhD Thesis of students from Spain, Portugal, Hungary, México, Argentina, Colombia, Costa Rica, Cuba, Nicaragua, and more than 50 Master Degree Students. He has been Visiting Research Schoolar/Professor at UCLA (Los Angeles US), UNC (Chapel Hill, North Carolina, US), Mount Sinai (NY), Miami University (FL), John Curtin School of Medical Research (Camberra, Australia), Debrecen (Hungary), Tartu (Estonia), Karolinska Institute (Stockholm), UFMG (Brazil).